Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)
Clinical trial NCT03748953 · COMPLETED
Trial details
- NCT number
- NCT03748953
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2023-12-06
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.